Lepu Biopharma

Developer of immunotherapies for cancer treatment

placeShanghai, Shanghai, China calendar_todayFounded 2018 groups463 employees language lepubiopharma.com

Innovation

27 patent families (3 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace accelerating. Cited 192 times.

YearFilings
20202
20213
20223
20235
202413
202516
20268

Investor mix

2 investors on record; lead investors include Shanghai Healthcare Capital.

Investor typeCountShare
Private equity2100%
Coming soon